Last reviewed · How we verify

Linolenate — Competitive Intelligence Brief

Linolenate (linolenic acid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: linolenic acid. Area: Cardiovascular.

marketed linolenic acid Fatty acid-binding protein, heart, Free fatty acid receptor 1, Peroxisome proliferator-activated receptor delta Cardiovascular Live · refreshed every 30 min

Target snapshot

Linolenate (linolenic acid).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Linolenate TARGET linolenic acid marketed linolenic acid Fatty acid-binding protein, heart, Free fatty acid receptor 1, Peroxisome proliferator-activated receptor delta

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (linolenic acid class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Linolenate — Competitive Intelligence Brief. https://druglandscape.com/ci/linolenic-acid. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: